Russian version English version
Volume 6   Issue 2   Year 2011
Saik O.V., Moshkin M.P., Baldin M.N., Grouznov V.M., Kozlov V.A., Samorokov S.N., Demenkov P.S., Ivanisenko V.A., Kolchanov N.A.

PPROMEDIA – Database of Chemical Substances the Potential Biomarkers of Diseases with the Meaning in Noninvasive Diagnostics

Mathematical Biology & Bioinformatics. 2011;6(2):250-263.

doi: 10.17537/2011.6.250.


  1. Corradi M, Mutti A. Exhaled breath analysis: from occupational to respiratory medicine. Acta Biomed. 2005;76:20-29.
  2. Phillips M, Cataneo RN, Ditkoff BA. Volatile markers of breast cancer in the breath. Breast J. 2003;9:184-191. doi: 10.1046/j.1524-4741.2003.09309.x
  3. Pabst F, Miekisch W, Fuchs P, Kischkel S, Schubert JK. Monitoring of oxidative and metabolic stress during cardiac surgery by means of breath biomarkers: an observational study. J Cardiothorac Surg. 2007;2.
  4. Phillips M, Herrera J, Krishnan S, Zain M, Greenberg J, Cataneo RN. Variation in volatile organic compounds in the breath of normal humans. J. Chromatogr B Biomed. Sci. Appl. 1999;729:75-88.
  5. Gordon SM, Szidon JP, Krotoszynski BK, Gibbons RD, O'Neill HJ. Volatile organic compounds in exhaled air from patients with lung cancer. Clin. Chem. 1985;31:1278-1282.
  6. Phillips M, Gleeson K, Hughes JM, Greenberg J, Cataneo RN, Baker L, McVay WP. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet. 1999;353:1930-1933. doi: 10.1016/S0140-6736(98)07552-7
  7. Ligor M, Ligor T, Bajtarevic A, Ager C, Pienz M, Klieber M, Denz H, Fiegl M, Hilbe W, Weiss W, Lukas P, Jamnig H, Hackl M, Buszewski B, Miekisch W, Schubert J, Amann A. Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry. Clin. Chem. Lab. Med. 2009;47(5):550-560.
  8. Novak BJ, Blake DR, Meinardi S, Rowland FS, Pontello A, Cooper DM, Galassetti PR. Exhaled methyl nitrate as a noninvasive marker of hyperglycemia in type 1 diabetes. Proc. Natl. Acad. Sci. U S A. 2007;104(40):15613-15618. doi: 10.1073/pnas.0706533104
  9. Probert CS, Jones PR, Ratcliffe NM. A novel method for rapidly diagnosing the causes of diarrhea. Gut. 2004;53(1):58-61. doi: 10.1136/gut.53.1.58
  10. Tangerman A, Meuwese-Arends MT, Jansen JB. Cause and composition of foetor hepaticus. Lancet. 1994;343.
  11. Van den Velde S, Nevens F, Van Hee P, van Steenberghe D, Quirynen M. GC-MS analysis of breath odor compounds in liver patients. J Chromatogr B Analyt Technol Biomed. Life Sci. 2008;875:344-348.
  12. Braden B, Lembcke B, Kuker W, Caspary WF. 13C-breath tests: current state of the art and future directions. Dig Liver Dis. 2007;39:795-805. doi: 10.1016/j.dld.2007.06.012
  13. Chen X, Xu F, Wang Y, Pan Y, Lu D, Wang P, Ying K, Chen E, Zhang W. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis. Cancer. 2007;110(4):835-844. doi: 10.1002/cncr.22844
  14. Poli D, Carbognani P, Corradi M, Goldoni M, Acampa O, Balbi B, Bianchi L, Rusca M, Mutti A. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study. Respir Res. 2005;14:6-71.
  15. Abaffy T, Duncan R, Riemer DD, Tietje O, Elgart G, Milikowski C, DeFazio RA. Differential Volatile Signatures from Skin, Naevi and Melanoma: A Novel Approach to Detect a Pathological Process. PLoS One. 2010;5(11). doi: 10.1371/journal.pone.0013813
  16. Qin T, Liu H, Song Q, Song G, Wang H, Pan Y, Xiong F, Gu K, Sun G, Chen Z. The Screening of Volatile Markers for Hepatocellular Carcinoma. Cancer Epidemiol Biomarkers Prev. 2010;19:2247-2253. doi: 10.1158/1055-9965.EPI-10-0302
  17. Liu C, Feng S, van Heemst J, McAdam KG. New insights into the formation of volatile compounds in mainstream cigarette smoke. Anal. Bioanal. Chem. 2010;396(5):1817-1830.
  18. Filipiak W, Sponring A, Filipiak A, Ager C, Schubert J, Miekisch W, Amann A, Troppmair J. TD-GC-MS analysis of volatile metabolites of human lung cancer and normal cells in vitro. Cancer Epidemiol Biomarkers Prev. 2010;19(1):182-195. doi: 10.1158/1055-9965.EPI-09-0162
  19. Claudio G, Calder PC. Effects of Fat and Fatty Acid Intake on Inflammatory and Immune Responses: A Critical Review. Ann. Nutr. Metab. 2009;55:123-139.
  20. Tkacova R. Systemic Inflammation in Chronic Obstructive Pulmonary Disease:May Adipose Tissue Play a Role? Review of the Literature and Future Perspectives. Mediators of Inflammation. 2010. doi: 10.1155/2010/585989
  21. Drager LF, Jun JC, Polotsky VY. Metabolic consequences of intermittent hypoxia: Relevance to obstructive sleep apnea. Best Practice & Research Clinical Endocrinology & Metabolism. 2010;24:843-851. doi: 10.1016/j.beem.2010.08.011
  22. Fern´andez-Riejos P, Najib S, Santos-Alvarez J, Mart´ın-Romero C, P´erez-P´erez A, Gonz´alez-Yanes C, S´anchez-Margalet V. Role of Leptin in the Activation of Immune Cells. Mediators of Inflammation. 2010.
  23. Yoshino T, Kusunoki N, Tanaka N, Kaneko K, Kusunoki Y, Endo H, Hasunuma T, Kawai S. Elevated Serum Levels of Resistin, Leptin, and Adiponectin are Associated with C-reactive Protein and also Other Clinical Conditions in Rheumatoid Arthritis. Intern Med. 2011:269-275. doi: 10.2169/internalmedicine.50.4306
  24. Andreelli F, Jacquier D, Troy S. Molecular aspects of insulin therapy in critically ill patients. Curr Opin Clin Nutr Metab Care. 2006;9(2):124-130. doi: 10.1097/01.mco.0000214571.97933.0a
  25. Suryaprabha P, Das UN, Ramesh G, Kumar KV, Kumar GS. Reactive oxygen species, lipid peroxides and essential fatty acids in patients with rheumatoid arthritis and systemic lupus erythematosus. Prostaglandins Leukot Essent Fatty Acids. 1991;43(4):251-255. doi: 10.1016/0952-3278(91)90038-7
  26. Jira W, Spiteller G. Dramatic increase of linoleic acid peroxidation products by aging, atherosclerosis, and rheumatoid arthritis. Adv. Exp. Med. Biol. 1999;469:479-483.
  27. Calder PC. Long-chain n-3 fatty acids and inflammation: potential application in surgical and trauma patients. Braz. J. Med. Biol. Res. 2003;36(4):433-446.
  28. Zhao X, Imig JD. Kidney CYP450 enzymes: biological actions beyond drug metabolism. Curr. Drug. Metab. 2003;4(1):73-84.
  29. Pompeia C, Lima T, Curi R. Arachidonic acid cytotoxicity: can arachidonic acid be a physiological mediator of cell death? Cell Biochem. Funct. 2003;21(2):97-104.
  30. Kanadaşi M, Cayli M, Demirtaş M, Inal T, Demir M, Koç M, Avkaroğullari M, Dönmez Y, Usal A, Alhan CC, San M. The effect of early statin treatment on inflammation and cardiac events in acute coronary syndrome patients with low-density lipoprotein cholesterol. Heart Vessels. 2006;21(5):291-297. doi: 10.1007/s00380-005-0901-1
  31. Chae JS, Kim OY, Paik JK, Kang R, Seo WJ, Jeong TS, Sweeney G, Lee SH, Lee JH. Association of Lp-PLA(2) activity and LDL size with interleukin-6, an inflammatory cytokine and oxidized LDL, a marker of oxidative stress, in women with metabolic syndrome. Atherosclerosis. 2011;218(2):499-506. doi: 10.1016/j.atherosclerosis.2011.06.036
  32. Saggini A, Anogeianaki A, Maccauro G, Tete S, Salini V, Caraffa A, Conti F, Fulcheri M, Galzio R, Shaik-Dasthagirisaheb YB. Cholesterol, cytokines and diseases. Int J Immunopathol Pharmacol. 2011;24(3):567-581.
  33. Koc H, King J, Teschl G, Unterkofler K, Teschl S, Mochalski P, Hinterhuber H, Amann A. The role of mathematical modeling in VOC analysis using isoprene as a prototypic example. J. Breath Res. 2011;5(3). doi: 10.1088/1752-7155/5/3/037102
  34. Straub RH, Weidler C, Demmel B, Herrmann M, Kees F, Schmidt M, Schölmerich J, Schedel J. Renal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosus. Ann. Rheum. Dis. 2004;63(8):961-968.
  35. Hennebert O, Chalbot S, Alran S, Morfin R. Dehydroepiandrosterone 7alpha-hydroxylation in human tissues: possible interference with type 1 11beta-hydroxysteroid dehydrogenase-mediated processes. J. Steroid Biochem. Mol. Biol. 2007;104:326-333.
  36. Dulos J, van der Vleuten MA, Kavelaars A, Heijnen CJ, Boots AM. CYP7B expression and activity in fibroblast-like synoviocytes from patients with rheumatoid arthritis: regulation by proinflammatory cytokines. Arthritis Rheum. 2005;52(3):770-778. doi: 10.1002/art.20950
Table of Contents Original Article
Math. Biol. Bioinf.
doi: 10.17537/2011.6.250
published in Russian

Abstract (rus.)
Abstract (eng.)
Full text (rus., pdf)


  Copyright IMPB RAS © 2005-2024